Skip to main content

Novel Tools to Detect Pre-Analytical Errors and Improve Specimen Quality: The Impact of Accurate Laboratory Results on Patien

Tracking # 20-1208264

Price not reported

5 (1 ratings)
Learn more
CE Broker Reporting Reported automatically
Method Broadcasted Interactive Event
Dates Contact provider

Course overview

Accurate laboratory results are crucial to effective patient care, yet errors can arise that are impactful, costly, and far too common. Preanalytical errors make up the majority of diagnostic testing, accounting for about 43 to 75% of all laboratory errors in published studies. Despite this, there are limited tools available to laboratorians to capture and prevent preanalytical error. In this webinar, Dr. Christopher Farnsworth will introduce studies from his own hospital and other institutions in which novel tools for detecting preanalytical error have been implemented. Further, Dr. Farnsworth will assess how these tools have been applied collaboratively with nursing and others within the hospital to improve laboratory results and patient outcomes.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

1h Category 1

Molecular Diagnostics Diplomate

1h Category 1

Toxicological Chemistry Diplomate

1h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General

Clinical Laboratory Supervisor

1h General

Clinical Laboratory Technician

1h General

Clinical Laboratory Technologist

1h General

Public Health Director

1h General

Public Health Supervisor

1h General

Public Health Technologist

1h General

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following faculty reported financial relationships:

  • Christopher Farnsworth, PhD, DABCC
  • Honorarium/Expenses: Abbott, Werfen
  • Consultant Fee: Abbott, Werfen, Cytovale
  • Grant/Research Support: Abbott, Roche, Beckman, Siemens, Sebia, Qiagen, Cepheid, Werfen, Biomerieux

Learner Feedback